Cargando…
Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB–IIA Lung Adenocarcinoma
BACKGROUND: The prognostic value of ground glass opacity (GGO) in stage IA non-small cell lung cancer (NSCLC) has been widely recognized. However, studies investigating its value in the related stage IB–IIA lung adenocarcinoma (LUAD) remains lacking. The impact of adjuvant chemotherapy (ACT) on path...
Autores principales: | Zhai, Wenyu, Gong, Li, Zheng, Yuzhen, Yan, Qihang, Lai, Renchun, Liang, Dachuan, Wong, Wingshing, Dai, Shuqin, Wang, Junye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990754/ https://www.ncbi.nlm.nih.gov/pubmed/35402251 http://dx.doi.org/10.3389/fonc.2022.851276 |
Ejemplares similares
-
Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2021) -
Significance of accurate hilar and intrapulmonary lymph node examination and prognostication in stage IA–IIA non-small cell lung cancer, a retrospective cohort study
por: Zhai, Wenyu, et al.
Publicado: (2020) -
Ground glass opacity featured lung adenocarcinoma in teenagers
por: Wu, Haoxuan, et al.
Publicado: (2021) -
Metagenomic analysis of the microbiome of lung adenocarcinoma with pure ground‐glass opacity
por: Zhao, Zhenyu, et al.
Publicado: (2022) -
Prognostic effect of ground-glass opacity in subcentimeter invasive lung adenocarcinoma
por: Bai, Jinsong, et al.
Publicado: (2023)